Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Medgenics Company Profile (NASDAQ:MDGN)

Consensus Ratings for Medgenics (NASDAQ:MDGN) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Medgenics (NASDAQ:MDGN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/21/2012Roth CapitalInitiated CoverageBuy$13.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/20/2012 forward)